Overview
Insomnia with sleep apnea involves difficulty initiating or maintaining sleep coexisting with breathing disturbances during sleep, often leading to fragmented sleep and daytime impairment. 1Diagnosis
Clinical history: Symptoms of insomnia (difficulty falling asleep, frequent awakenings, early morning awakenings) and sleep apnea (snoring, witnessed apneas, daytime sleepiness).
Sleep studies: Polysomnography (PSG) is essential for confirming sleep apnea and assessing sleep architecture.
Questionnaires: Insomnia Severity Index (ISI) and Epworth Sleepiness Scale (ESS) can aid in evaluation.Management
First-line treatments:
- Behavioral interventions: Cognitive-behavioral therapy for insomnia (CBT-I).
- Sleep hygiene: Practical sleep hygiene practices and adaptive bedtime routines.
Adjunctive treatments:
- Melatonin: Low-dose melatonin (30-60 minutes before bedtime) may be considered in children over 2 years old if behavioral interventions are ineffective. 1Special Populations
Pediatrics: Low-dose melatonin can be used in children over 2 years old for sleep onset insomnia when behavioral measures fail. Monitor efficacy and adverse effects closely. 1Key Recommendations
Implement behavioral interventions, including CBT-I and sleep hygiene practices, as the initial approach for managing insomnia with sleep apnea. (Evidence: Expert opinion) 1
Consider low-dose melatonin (30-60 minutes before bedtime) as an adjunctive therapy in children over 2 years old with persistent sleep onset insomnia after non-pharmacological interventions. Monitor for efficacy and side effects. (Evidence: Expert opinion) 1References
1 Bruni O, Breda M, Nobili L, Fietze I, Capdevila ORS, Gronfier C. European expert guidance on management of sleep onset insomnia and melatonin use in typically developing children. European journal of pediatrics 2024. link